By: Stephanie Kawecki On: September 24, 2024 In: MixComm, Portfolio News

Sivers Semiconductors and Ayar Labs will hold a joint live demonstration, showing the Sivers Semiconductors 16-wavelength distributed feedback (DFB)...

Read more
By: Stephanie Kawecki On: September 24, 2024 In: Portfolio News, PteroDynamics

PteroDynamics Inc., an innovator in autonomous vertical takeoff and landing (VTOL) aircraft systems, today announced the successful demonstration of...

Read more
By: Stephanie Kawecki On: September 24, 2024 In: Mattiq, Portfolio News

Mattiq today announced the appointment of Duane Dickson as Chief Commercial Officer (CCO). Duane’s decades of experience and vast...

Read more
By: Stephanie Kawecki On: September 17, 2024 In: Linnaeus, Portfolio News

Linnaeus Therapeutics, Inc. continues to push boundaries in oncology with promising new data on LNS8801. Presented at the 2024...

Read more

Actuate Therapeutics, Inc. (NASDAQ: ACTU) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation...

Read more

Actuate Therapeutics, Inc. (NASDAQ: ACTU) announced that it will present at the H.C. Wainwright 26th Annual Global Investment Conference taking...

Read more
By: Stephanie Kawecki On: September 9, 2024 In: Portfolio News, Provivi

Provivi and Syngenta Biologicals today announced a collaboration to develop and commercialize new pheromone-based biological solutions to effectively and...

Read more
By: Stephanie Kawecki On: September 9, 2024 In: MemVerge, Portfolio News

With the rising demand for real-time data processing, CXL is emerging as a key innovation for modern data centers,...

Read more

Actuate Therapeutics, Inc., rang the Nasdaq opening bell in celebration of their IPO. This marks the start of an...

Read more
By: Stephanie Kawecki On: August 20, 2024 In: Linnaeus, Portfolio News

The South Jersey company developing new cancer therapies based on the discoveries of a Penn researcher, Linnaeus Therapeutics, has...

Read more